These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17888666)

  • 1. Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indol-2-substitutedacetates.
    Liu J; Cui G; Zhao M; Cui C; Ju J; Peng S
    Bioorg Med Chem; 2007 Dec; 15(24):7773-88. PubMed ID: 17888666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel amino-substituted xanthenones and benzo[b]xanthenones: evaluation of their antiproliferative activity and their ability to overcome multidrug resistance toward MES-SA/D x 5 cells.
    Kostakis IK; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H; Kletsas D
    Bioorg Med Chem; 2006 May; 14(9):2910-34. PubMed ID: 16376546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indole-2-substituted acetates: One-pot-preparation, anti-tumor activity, docking toward DNA and 3D QSAR analysis.
    Liu J; Zhao M; Qian K; Zhang X; Lee KH; Wu J; Liu YN; Peng S
    Bioorg Med Chem; 2010 Mar; 18(5):1910-7. PubMed ID: 20171109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl (11aS)-1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo-[3',4':1,2]pyridin[3,4-b]indol-2-substituted acetates: synthesis and three-dimensional quantitative structure-activity relationship investigation as a class of novel vasodilators.
    Liu J; Zhao M; Cui G; Zhang X; Wang J; Peng S
    J Med Chem; 2008 Aug; 51(15):4715-23. PubMed ID: 18616237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
    Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
    Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and antiproliferative activity of some novel aminosubstituted xanthenones, able to overcome multidrug resistance toward MES-SA/Dx5 cells.
    Kostakis IK; Tenta R; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H; Kletsas D
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5057-60. PubMed ID: 16169719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
    Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
    Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
    Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of 1-furfuryl-indolin-2-one derivatives and preliminary evaluation of their antitumor activities].
    Dong XC; Zhou FS; Zheng JB; Wen R
    Yao Xue Xue Bao; 2008 Jan; 43(1):54-9. PubMed ID: 18357732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents.
    Karki SS; Panjamurthy K; Kumar S; Nambiar M; Ramareddy SA; Chiruvella KK; Raghavan SC
    Eur J Med Chem; 2011 Jun; 46(6):2109-16. PubMed ID: 21439690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cytotoxic activities of 1-benzylidine substituted beta-carboline derivatives.
    Cao R; Yi W; Wu Q; Guan X; Feng M; Ma C; Chen Z; Song H; Peng W
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6558-61. PubMed ID: 18952426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
    Singh P; Kaur P; Luxami V; Kaur S; Kumar S
    Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 5,6-dimethyl-9-methoxy-1-phenyl-6H-pyrido[4,3-b]carbazole derivatives and their cytotoxic activity.
    Jasztold-Howorko R; Pelczynska M; Nasulewicz A; Wietrzyk J; Opolski A
    Arch Pharm (Weinheim); 2005 Nov; 338(11):556-61. PubMed ID: 16281305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones.
    Kwak JH; Namgoong K; Jung JK; Han SB; Cho J; Kim HM; Park SG; Lee K; Kang JS; Lee H
    Arch Pharm Res; 2010 May; 33(5):663-7. PubMed ID: 20512462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
    Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
    Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thienopyridine and benzofuran derivatives as potent anti-tumor agents possessing different structure-activity relationships.
    Hayakawa I; Shioya R; Agatsuma T; Furukawa H; Sugano Y
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3411-4. PubMed ID: 15177443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensely potent doxorubicin analogues: structure-activity relationship.
    Farquhar D; Cherif A; Bakina E; Nelson JA
    J Med Chem; 1998 Mar; 41(6):965-72. PubMed ID: 9526570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.